MedPath

?Effects of Metronidazole gel and tablets in gingival disease treatment

Phase 3
Recruiting
Conditions
Chronic Periodontitis.
Chronic periodontitis
K05.3
Registration Number
IRCT20210408050898N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patient diagnosed with chronic periodontitis with at least three non-adjacent pockets with probing depth equal to or greater than 4 mm.
Patients with systemic health.
Patients who have not taken any anti-inflammatory drugs or antibiotics in the last six months.
Patients with at least 15 teeth (except third molars) in their mouth.
Patients with proper cooperation.
Patients who have signed an informed written consent form.

Exclusion Criteria

Patients with medical problems who need antibiotic prophylaxis or treatment intervention.
Patients who have had periodontal treatment in the last six months.
Patients who have used drugs that affect their periodontal status (such as antibiotics, anti-inflammatory drugs, anticonvulsants, immunosuppressive drugs, and calcium channel blockers) in the last six months.
Patients who have undergone orthodontic treatment.
Pregnant and lactating patients.
Patients with systemic diseases such as diabetes and immunological disorders.
O’Leary plaque index more than 15% after proper oral hygiene training.
History of Metronidazole allergy.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pocket Probing Depth. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Periodontal Probe.;Clinical Attachment Level. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Periodontal Probe.;Bleeding On Probing. Timepoint: At the beginning of the study (before the intervention) and three months after the intervention. Method of measurement: Visual.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath